Form 8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d)

of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): December 3, 2015

 

 

PSIVIDA CORP.

(Exact Name of Registrant as Specified in Its Charter)

 

 

 

Delaware   000-51122   26-2774444

(State or Other Jurisdiction

of Incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

480 Pleasant Street

Watertown, MA 02472

(Address of Principal Executive Offices) (Zip Code)

(617) 926-5000

(Registrant’s Telephone Number, Including Area Code)

Not applicable

(Former Name or Former Address, if Changed Since Last Report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 5.07 Submission of Matters to a Vote of Security Holders.

The Annual Meeting of Stockholders of pSivida Corp. (the “Company”) was held on December 3, 2015. The stockholders elected each of the Company’s nominees for director, approved the stock option grant to the Company’s Chief Executive Officer, approved the stock option grants to the Company’s non-executive directors, approved, on an advisory basis, the Company’s 2015 executive compensation and ratified the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for fiscal year 2016. The proposals below are described in detail in the Company’s definitive proxy statement filed with the SEC on October 23, 2015.

The results are as follows:

 

  1. Election of Directors:

 

    

Vote type

   Vote Results  

David J. Mazzo

   For      10,740,793   
   Withheld      291,914   
   Non Votes      9,917,998   

Paul Ashton

   For      10,741,207   
   Withheld      291,500   
   Non Votes      9,917,998   

Michael Rogers

   For      10,748,500   
   Withheld      284,207   
   Non Votes      9,917,998   

Peter G. Savas

   For      10,305,227   
   Withheld      727,480   
   Non Votes      9,917,998   

Douglas Godshall

   For      10,740,618   
   Withheld      292,089   
   Non Votes      9,917,998   

James Barry

   For      10,747,255   
   Withheld      285,452   
   Non Votes      9,917,998   

 

  2. Approval of stock option grant to CEO Paul Ashton.

 

Vote type

   Vote Results  

For

     9,620,898   

Against

     1,296,356   

Abstain

     115,453   

Non Votes

     9,917,998   


  3. Approval of stock option grant to the following non-executive directors:

 

    

Vote type

   Vote Results  

James Barry

   For      7,341,718   
   Against      3,600,612   
   Abstain      90,377   
   Non Votes      9,917,998   

Douglas Godshall

   For      7,324,461   
   Against      3,618,813   
   Abstain      89,433   
   Non Votes      9,917,998   

Michael Rogers

   For      7,329,767   
   Against      3,613,563   
   Abstain      89,377   
   Non Votes      9,917,998   

Peter G. Savas

   For      6,903,427   
   Against      4,039,847   
   Abstain      89,433   
   Non Votes      9,917,998   

David J. Mazzo

   For      7,324,517   
   Against      3,618,813   
   Abstain      89,377   
   Non Votes      9,917,998   

 

  4. Approval on an advisory basis of pSivida Corp.’s 2015 executive compensation.

 

Vote type

   Vote Results  

For

     8,139,098   

Against

     2,809,807   

Abstain

     83,802   

Non Votes

     9,917,998   

 

  5. Ratification of the appointment of Deloitte & Touche LLP.

 

Vote type

   Vote Results  

For

     20,335,389   

Against

     587,179   

Abstain

     28,137   

Non Votes

     0   


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

   

PSIVIDA CORP.

Date: December 4, 2015     By:  

/s/ Lori Freedman

    Lori Freedman, Vice President, Corporate Affairs, General Counsel and Secretary